Trialwell raises £195k in pre-seed funding from Nova to expand its clinical trial platform
Liverpool-based venture builder Nova has provided £195k alongside hands-on startup support.
£195KPre-Seed
Trialwell operates an online digital platform that helps people discover and enrol in clinical trials. The service matches users with suitable health studies based on their personal profiles.
Trialwell has secured £195k in pre-seed funding from venture builder Nova. The capital will support the development and marketing of the digital platform.
Founder Laura Holland pitched the concept to the Nova investment committee earlier this year. The funding package also includes access to product developers, marketing specialists, and business mentors from Nova.
Investor perspective
"We are delighted to welcome Laura and the Trialwell team onboard. Laura’s passion and commitment for helping people’s health and wellbeing is what led us to invest in this startup. We firmly believe that this venture will positively impact the health and wellbeing of many. This is something that we at Nova, are excited to be part of."
OG
Olivia Greenberg
Chief Growth Officer, Nova
Use of funds
- 01Continue product development
- 02Invest in sales and marketing